BEIJING, April 8 (Xinhua) -- A group of Chinese experts Monday shared experience in fighting against the COVID-19 outbreak with experts from the United States and Europe at the International Symposium on COVID-19 Treatment (Webcast).
In combating the COVID-19, integrating Chinese and western medicine treatment is the highlight of China's plan. Song Jun, a senior official with the China Association for Science and Technology, said that in the absence of effective drugs and vaccines, China has developed a systematic program to treat patients with integrated traditional Chinese and western medicines.
Tong Xiaolin, a member of the Chinese Academy of Sciences, said at the conference that intervention of Chinese medicine at the early stage plays a crucial role in controlling the COVID-19.
"The core is early treatment and early intervention, focusing on the community and putting the community in the first line of defense," Tong said.
Xia Wenguang, Hubei Provincial Hospital of Integrated Chinese and Western Medicines, speaks at the symposium.
Xia Wenguang, Hubei Provincial Hospital of Integrated Chinese and Western Medicines, said the focus is shifting from treatment to rehabilitation in China.
China adhered to integrating traditional Chinese and western medicines, and carried out clinical examination, rehabilitation assessment and rehabilitation treatment, and has achieved good results, he said.
"Information and experience shared at the conference is very important to us. The COVID-19 is a global health crisis, and only by working together can we overcome the invisible enemy," said Maryland State Senator Susan Lee.
Christoph Gutenbrunner, director of the rehabilitation center at Germany's University of Hannover, speaks at the conference.
Christoph Gutenbrunner, director of the rehabilitation center at Germany's University of Hannover, said Germany has received many effective treatment suggestions, including many from China, and after collating they can provide reference for front-line medical personnel.
With the support of the China Association of Chinese Medicine and assistance from relative organizations, Tasly Holding Group initiated the symposium to share treatment and clinical experience with the world.
Tasly has been committed to promoting internationalization of traditional Chinese medicine, and it has established a group of R&D and service institutions in the U.S., Australia and some European countries, said Yan Kaijing, executive chairman of Tasly Holding Group. (Edited by Yang Qi with Xinhua Silk Road, kateqiyang@xinhua.org)
A single purchase
